Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$4.39 - $9.08 $54,874 - $113,500
-12,500 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$3.86 - $5.07 $22,774 - $29,913
-5,900 Reduced 32.07%
12,500 $54,000
Q3 2020

Nov 13, 2020

BUY
$4.11 - $6.45 $15,207 - $23,865
3,700 Added 25.17%
18,400 $76,000
Q2 2020

Aug 13, 2020

BUY
$5.75 - $11.99 $84,525 - $176,253
14,700 New
14,700 $88,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.